zm 241385 has been researched along with 9-(tetrahydro-2-furyl)-adenine in 2 studies
| Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (9-(tetrahydro-2-furyl)-adenine) | Trials (9-(tetrahydro-2-furyl)-adenine) | Recent Studies (post-2010) (9-(tetrahydro-2-furyl)-adenine) |
|---|---|---|---|---|---|
| 401 | 3 | 124 | 274 | 0 | 56 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huxley, VH; Wang, J | 1 |
| Alarcón, M; Caballero, J; Fuentes, E; Palomo, I; Rojas, A | 1 |
2 other study(ies) available for zm 241385 and 9-(tetrahydro-2-furyl)-adenine
| Article | Year |
|---|---|
Adenosine A2A receptor modulation of juvenile female rat skeletal muscle microvessel permeability.
Topics: Adenine; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Aging; Animals; Arterioles; Cell Membrane Permeability; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gene Expression Regulation; Muscle, Skeletal; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; RNA, Messenger; Serum Albumin; Triazines; Triazoles; Vasodilator Agents; Venules | 2006 |
Chlorogenic acid inhibits human platelet activation and thrombus formation.
Topics: Adenine; Adenosine Triphosphate; Animals; Binding Sites; Bleeding Time; Cell Communication; Cell Line; Cell Survival; Chlorogenic Acid; Collagen; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Hemorheology; Humans; Inflammation Mediators; Leukocytes; Mice; Models, Molecular; P-Selectin; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Receptor, Adenosine A2A; Thrombosis; Triazines; Triazoles | 2014 |